Maze Therapeutics (MAZE) earnings, Aug 11, 2026: EPS +1%, stock +0.8%
In brief
Maze Therapeutics reported on Aug 11, 2026. Earnings per share changed +1% year over year, 6.0% below the estimate; revenue 0%. The stock opened with a +0.6% gap and closed the day +0.8% (Aug 12, 2026). The stock is now 39.4% below its 52-week high, +7.5% over 12 months. Next report: Nov 5, 2026.
EPS vs estimate−6.0%
EPS, YoY+1%
Revenue, YoY0%
Gap · day+0.6% · +0.8%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| May 12, 2026 | +0.9% | +4.6% |
| Aug 11, 2026 | +0.6% | +0.8% |
Next-quarter estimates, ratings and the MAZE chart are in the terminal.
Open the terminalFAQ
When is Maze Therapeutics's next earnings report?
Nov 5, 2026. The date comes from daily data and is corrected if the company moves it.
How did Maze Therapeutics stock react to the report?
Opening gap +0.6%, day's result +0.8%.
Did Maze Therapeutics's earnings grow?
Earnings per share rose 1% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.